Mister ED: Once again, you are giving credit for the publishing of this article to the wrong company. At the current time, Pfizer has absolutely nothing to do with the placement of articles on MUSE or Viagra. If Pfizer was found to have promoted Viagra or issused comparative competitive press releases prior to approval, it would be a major FDA violation that would seriously jeopardize Viagra's NDA priority review. PFE and any other Big Pharma company would never break these well-known FDA regulations.
The Barrons' article simply reviews VVUS' slide over the last month and is a "follow-up" to their 2/12/97 article on VVUS. "Well, we were right."
Here is the concluding paragraph that questions whether MUSE will win out over the injectables for the non-responders to Viagra:
"Dr. Irwin Goldstein, a urology researcher at Boston University, says
that MUSE does work in 20%-50% of patients, but he expects impotence
pills like Pfizer's Viagra to take over the market once they get FDA
approval. Right now Viagra is on a six-month "fast track" for possible
approval by the second quarter of 1998. The big question for MUSE, says Dr. Barada (professor of surgery at SUNY, Albany), is whether it will work for patients that are not helped by pills like Viagra. If MUSE won't do the trick for guys who don't respond to Viagra, but injections do work for them, then Barada guesses that MUSE will be "out of loop"."
BigKNY3 |
